Sequence-Controlled Multi-Block Glycopolymers to Inhibit DC-SIGN-gp120 Binding
Sequence-Controlled Multi-Block Glycopolymers to Inhibit DC-SIGN-gp120 Binding
复制标题
DOI:
10.1002/anie.201300068
复制
发表时间:
2013-01-01
影响因子:
16.6
通讯作者:
Haddleton, David M.
中科院分区:
文献类型:
--
作者:
Zhang, Qiang;Collins, Jennifer;Haddleton, David M.
Glycan-protein interactions are essential for many physiological processes including cell-cell recognition, cell adhesion, cell signalling, pathogen identification and differentiation. Dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN; CD209) is a C-type lectin (carbohydratebinding protein) present on both macrophages and dendritic cell subpopulations and play a critical role in many cell interactions. DC-SIGN binds to microorganisms and host molecules by recognizing surface rich mannose containing glycans through multivalent glycan-protein interactions and serves a target for several viruses such as human immunodeficiency virus (HIV) and hepatitis C virus (HCV).[1] Carbohydrate binding proteins (CBP) have been suggested as potential candidate microbiocides for the prevention of HIV infection.[2] However, the isolation of natural CBPs is relatively difficult due to their hydrophilic nature and they show notably low affinities to virus.[3],[4] and thus synthetic lectins are of interest for carbohydrate recognition studies.[5] Alternatively, non-carbohydrate inhibitors of mammalian lectins can be used to prevent the interaction between DC-SIGN and gp120.[6] The architectures of the multivalent ligands have a great effect on carbohydrate binding to lectins and the use of linear polymers on effective lectin binding has been demonstrated by several research groups.[7]